TY  - JOUR
AU  - Rodriguez-Arboli, Eduardo
AU  - Martinez-Cuadron, David
AU  - Rodriguez-Veiga, Rebeca
AU  - Carrillo-Cruz, Estrella
AU  - Gil-Cortes, Cristina
AU  - Serrano-Lopez, Josefina
AU  - Bernal Del Castillo, Teresa
AU  - Martinez-Sanchez, Maria Del Pilar
AU  - Rodriguez-Medina, Carlos
AU  - Vidriales, Belen
AU  - Bergua, Juan Miguel
AU  - Benavente, Celina
AU  - Garcia-Boyero, Raimundo
AU  - Herrera-Puente, Pilar
AU  - Algarra, Lorenzo
AU  - Sayas-Lloris, Maria Jose
AU  - Fernandez, Rosa
AU  - Labrador, Jorge
AU  - Lavilla-Rubira, Esperanza
AU  - Barrios-Garcia, Manuel
AU  - Tormo, Mar
AU  - Serrano-Maestro, Alfons
AU  - Sossa-Melo, Claudia Lucia
AU  - Garcia-Belmonte, Daniel
AU  - Vives, Susana
AU  - Rodriguez-Gutierrez, Juan Ignacio
AU  - Albo-Lopez, Carmen
AU  - Garrastazul-Sanchez, Maria Paz
AU  - Colorado-Araujo, Mercedes
AU  - Mariz, Jose
AU  - Sanz, Miguel Angel
AU  - Perez-Simon, Jose Antonio
AU  - Montesinos, Pau
PY  - 2020
DO  - 10.1016/j.jtct.2020.12.029
UR  - http://hdl.handle.net/10668/17556
T2  - Transplantation and cellular therapy
AB  - Acute myeloid leukemia (AML) with intermediate risk cytogenetics (IRcyto) comprises a variety of biological entities with distinct mutational landscapes that translate into differential risks of relapse and prognosis. Optimal postremission therapy...
LA  - en
PB  - Elsevier
KW  - Acute myeloid leukemia
KW  - Allogeneic stem cell transplant
KW  - Autologous stem cell transplant
KW  - Cytogenetic Analysis
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Nucleophosmin
KW  - Remission Induction
KW  - Transplantation, Homologous
TI  - Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.
TY  - research article
VL  - 27
ER  -